Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $4.73 | $4.36 | 8.46% | 36.38x | 19.71x | 10.80x | 20.24x | 0.38x | -$74.32M | -4.38% | $83.79M | 0.23 | $1.78B | 43.54 | ||
| CORT | CORCEPT THERAPEUTICS INC | $75.03 | $40.42 | 85.62% | 49.69x | 35.33x | 8.30x | 9.85x | 0.69x | $194.62M | 2.43% | $833.74M | 7.82 | $8.12B | 73.22 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $314.15 | $74.27 | 323.01% | 118.55x | 32.39x | 24.71x | 6.53x | 1.55x | $90.43M | 1.44% | $961.76M | 48.18 | $7.38B | 74.95 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.20 | $8.12 | 222.49% | 119.09x | 84.57x | 6.75x | 13.58x | 1.13x | $59.71M | 1.74% | $243.97M | 1.86 | $3.39B | 72.54 | ||
| RPRX | ROYALTY PHARMA PLC | $68.77 | $35.64 | 92.97% | 44.95x | 12.57x | 11.72x | 4.03x | 0.74x | $2.89B | 9.43% | $9.80B | 21.96 | $47.52B | 45.54 | ||
| KRYS | KRYSTAL BIOTECH INC | $303.06 | $78.51 | 286.01% | 39.56x | 38.67x | 19.09x | 6.26x | 2.19x | $310.08M | 3.46% | $1.44B | 48.48 | $8.53B | 32.11 | ||
| VCEL | VERICEL CORP | $58.39 | $8.68 | 572.94% | 88.47x | 77.36x | 9.22x | 7.76x | 3.21x | $57.89M | 1.94% | $384.17M | 7.51 | $2.94B | 54.45 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $98.76 | $14.84 | 565.32% | 69.06x | 75.26x | 8.16x | 10.93x | 3.74x | $197.20M | 2.55% | $710.19M | 9.08 | $7.69B | 50.56 | ||
| TGTX | TG THERAPEUTICS INC | $63.38 | $23.07 | 174.70% | 20.58x | 61.83x | 11.24x | 16.06x | 2.29x | $17.39M | 0.19% | $604.08M | 4.26 | $9.97B | 71.62 | ||
| ADMA | ADMA BIOLOGICS INC | $12.79 | $7.03 | 82.03% | 16.19x | 15.87x | 5.51x | 6.47x | 1.19x | $132.91M | 4.64% | $438.51M | 1.96 | $2.91B | 11.52 | ||
| HALO | HALOZYME THERAPEUTICS INC | $102.92 | $76.12 | 35.21% | 24.27x | 11.36x | 6.50x | -212.42x | 0.56x | $885.88M | 7.56% | -$55.24M | -0.49 | $13.95B | 17.32 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $243.55 | $132.85 | 83.33% | 66.91x | 15.94x | 3.34x | 3.73x | 0.64x | $1.65B | 10.49% | $4.19B | 64.79 | $19.23B | 16.78 | ||
| TECH | BIO-TECHNE CORP | $72.83 | $16.43 | 343.30% | 66.21x | 35.07x | 9.30x | 5.28x | 1.98x | $308.20M | 2.70% | $2.17B | 13.81 | $11.38B | 34.09 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.14 | $8.06 | 50.57% | 9.56x | 10.63x | 4.88x | 3.02x | 1.83x | $87.07M | 12.08% | $238.92M | 4.02 | $601.47M | 6.26 | ||
| INCY | INCYTE CORP | $121.89 | $54.18 | 124.98% | 58.32x | 35.32x | 4.12x | 4.40x | 0.84x | $684.87M | 2.76% | $5.64B | 27.76 | $21.60B | 24.08 | ||
| EXEL | EXELIXIS INC | $71.74 | $32.10 | 123.50% | 20.79x | 20.49x | 7.09x | 9.55x | 1.39x | $1.16B | 6.56% | $1.83B | 7.43 | $17.36B | 15.54 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $550.87 | $147.91 | 272.44% | 35.15x | 29.64x | 10.78x | 6.68x | 2.29x | $3.20B | 2.29% | $20.91B | 82.48 | $141.17B | 28.03 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $919.96 | $497.75 | 84.82% | 19.57x | 13.10x | 5.54x | 2.84x | 1.02x | $3.83B | 4.09% | $33.50B | 329.39 | $94.22B | 15.08 | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $2.36 | $6.44 | -63.34% | 4.00x | -57.84x | N/A | 1.83x | 0.20x | -$21.06M | -4.83% | $139.32M | 0.76 | $246.70M | 196.26 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.78 | $28.82 | 17.19% | 10.93x | 8.81x | 1.99x | 1.85x | 0.73x | $322.93M | 16.37% | $1.07B | 18.36 | $1.49B | 5.48 | ||
| UTHR | UNITED THERAPEUTICS CORP | $582.46 | $214.24 | 171.87% | 20.39x | 21.75x | 7.80x | 3.95x | 2.27x | $867.20M | 3.49% | $6.28B | 146.98 | $23.62B | 14.62 | ||
| VCYT | VERACYTE INC | $25.92 | $9.83 | 163.57% | 16.30x | 13.24x | 3.59x | 1.46x | 3.49x | $161.95M | 7.76% | $1.43B | 17.80 | $1.93B | 13.54 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.